Zantac’s manufacturers were on a roll. Their defense had exacted a spate of favorable decisions and jury verdicts. Yet, on October 9, Glaxo Smith Kline (GSK) suddenly settled 93% of the remaining ...

Zantac’s Developer Settles Lawsuits Claiming Cancer Link GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

GSK Plc will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its reflux medication Zantac was contaminated with a suspected carcinogen. (Chris Walker ...

Over 75,000 plaintiffs filed suit in Delaware Superior Court alleging that ranitidine, which several manufacturers market under the trade name Zantac, caused their cancer. More specifically, they ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

What You Need to Know The verdict, in a case brought by plaintiff Angela Valadez, comes two years after a federal judge tossed all the plaintiffs' experts in the Zantac multidistrict litigation ...

After propensity score matching among more than 1.18 million individuals across seven countries, the incidence of cancer was 15.92 cases per 1,000 person-years for those who used ranitidine versus ...

In 2017, Paris-based Sanofi acquired U.S. over-the-counter rights to Zantac, transferred in an exchange agreement with Germany-based Boehringer, which had purchased them in 2006. According to Sanofi’s ...

More than 100,000 Zantac cases remain active in state courts around the country. The claim is not that Zantac (ranitidine)an antacid, per se, is dangerous. Rather, it is that, over time and intense ...

Zantac manufacturers still face more than 70,000 state court cases, Businessweek reports. That figure includes defendants who marketed Zantac after GSK sold the rights, plus generic manufacturers.